Skip to main content
RESOURCE

Testosterone Injections vs Cream: Which One Should You Actually Start On?

Compare an FDA-approved testosterone injection with compounded cream across evidence, FDA status, transfer risk, hematocrit, fertility, cost, routine, and fit.

By TRT Provider Guide

Published 2026-09-18 · Last updated 2026-09-18

Last verified: 2026-09-18

Researched and written by the TRT Provider Guide editorial team. Not clinically reviewed. Educational information, not medical advice.

Educational resource
Evidence Cited

Last verified: September 2026 · Researched and written by the TRT Provider Guide editorial team · Not clinically reviewed

Educational information, not medical advice. TRT Provider Guide does not diagnose low testosterone, prescribe medication, or decide whether treatment is right for you. If you have chest pain, trouble breathing, or another emergency symptom, get urgent or emergency care now.

Some links on this page are affiliate links. If you start care through one, we may earn a commission at no extra cost to you. It does not change what we found — and some of the lower-cost care routes on this page pay us nothing.

Testosterone injections vs cream comes down to this: between an FDA-approved testosterone injection and a compounded testosterone cream, injections are the more evidence-supported default when both are clinically appropriate; cream is a reasonable exception when needles are a real barrier or a clinician has a patient-specific reason to use a compounded topical. The biggest constraint is easy to miss: compounded testosterone cream is not FDA-approved.

That does not mean compounded cream is illegal or useless. It means the finished cream has not gone through FDA approval, and research or labeling from an FDA-approved gel cannot automatically be treated as evidence about the cream a clinic wants to prescribe.

The other big difference is your household. Topical testosterone creates a skin-transfer problem that injections do not. In a study in the FDA-approved AndroGel 1.62% label, direct contact with an uncovered application site increased testosterone exposure in female partners by about 280% on average; covering the site with a T-shirt reduced the average increase to about 6%. Those numbers are gel data, not compounded-cream data — and that distinction matters.


Best for you / not for you

Start the conversation about injections if… Start the conversation about compounded cream if…
You want an FDA-approved testosterone product Needles are a real barrier to following treatment
You want to avoid topical skin-transfer precautions Your clinician has a patient-specific reason for a compounded topical
You want the treatment format most likely to have ordinary pharmacy and insurance pathways You accept that the finished cream is not FDA-approved
Young children or a pregnant partner make topical exposure hard to manage You can follow the exact handling instructions from the prescribing clinician and pharmacy
You would rather avoid day-to-day skin-absorption variables A daily topical routine is more realistic for you than injections

This isn't a format question yet if: low testosterone has not been properly evaluated, you are trying to conceive now or planning fertility in the near term, or you have a history or finding that needs more direct medical evaluation. Current endocrine guidance calls for compatible symptoms or signs plus consistently low testosterone confirmed with appropriate repeat early-morning testing — not a quiz, one symptom, or one isolated number.


Testosterone injections vs cream: the short version

Decision factor Testosterone injection Compounded testosterone cream
FDA-approved finished product available? Yes No
Testosterone controlled substance? Yes — Schedule III Yes — Schedule III
Needles Yes No
Depends on skin absorption No Yes
Skin-transfer concern No application-site transfer pathway Yes — get product-specific handling instructions
Routine Injection schedule set by the prescriber Recurring topical application; exact schedule is prescription-specific
Hematocrit Can rise and must be monitored Can rise and must be monitored; cream-specific comparative evidence is limited
Evidence depth Strong product-specific labeling for approved injections Thinner and product-specific because compounded preparations differ
Fertility Can suppress sperm production Can suppress sperm production
Insurance path Often easier because approved products exist Usually harder because the finished product is compounded
Biggest practical drawback Needles and formulation/schedule-dependent peaks and troughs Daily handling, absorption variability, product variability, transfer precautions

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.


The honest part first: the cheapest route may not involve us

If you already have a doctor who will evaluate you, write an appropriate prescription, and coordinate monitoring, an FDA-approved testosterone product through an ordinary pharmacy can cost much less than a full-service cash-pay telehealth program. GoodRx listed testosterone cypionate starting around $29.95 at the time of this audit, but discount-card prices change by pharmacy, location, strength, quantity, and prescription.

Nobody pays us when you take a local-prescriber route. For a lot of men, that is the right answer.

Online programs cost more because the bill can include more than medication: clinician access, membership fees, testing, follow-up, fulfillment, support, and shipping. That package can be worth the extra cost if it solves a real access problem. It can also be a bad deal if you already have a clinician who will handle the same work.

If the local route already failed you, or you have been putting this off because coordinating the appointment, labs, and follow-up felt like too much, keep reading. The rest of this page is built to help you compare the actual tradeoffs instead of choosing a format from a headline.

▶ Leaning one way, but not locked in?

Male Excel currently publishes both testosterone cypionate injections and compounded testosterone cream in its treatment menu. That makes it relevant if you want one program where a clinician can discuss either format instead of choosing a clinic solely because it sells one.

See Male Excel's current pricing and what is included →

Affiliate link. Male Excel is a cash-pay telehealth program. Its public pricing and treatment details were re-checked in September 2026. A prescription is a clinical decision, not a guaranteed outcome of intake.


First, be sure what "cream" actually means

In the United States, “testosterone cream” generally means a compounded product — one prepared by a compounding pharmacy for a prescription. FDA-approved topical testosterone products exist, but an approved gel and a compounded cream are not the same finished drug and should not be treated as interchangeable in labeling, evidence, strength, instructions, or coverage.

Here is the plain version. When a drug is FDA-approved, FDA has reviewed that finished product for safety, effectiveness, and quality for its approved use. Compounded drugs are not FDA-approved, and FDA says it does not verify their safety, effectiveness, or quality before they are marketed.

That does not make compounding automatically bad. FDA recognizes that compounded drugs can meet a patient's medical need when an FDA-approved drug cannot appropriately do so. The point is narrower and more useful: a compounded cream should have a reason to exist for that patient, and claims about another product should not be borrowed as if they were cream data.

Research done on AndroGel is research on AndroGel. A compounded cream can have a different base, concentration, application site, and set of pharmacy instructions.

If what you actually mean by “cream” is an FDA-approved gel, read our testosterone injections vs gel comparison instead. This page is about injections versus pharmacy-compounded testosterone cream.


Testosterone injections vs cream: the full decision matrix

Injections trade a needle for freedom from skin absorption and topical transfer. Compounded cream removes the needle but adds a recurring skin routine, individual absorption, and a regulatory difference: the finished cream has not been FDA-approved. Those two facts drive most of the practical decision.

We built this table because you would otherwise need to pull the answer from FDA labeling, FDA compounding guidance, clinical guidelines, pharmacokinetic studies, and several provider pages.

Decision factor Testosterone injection Compounded testosterone cream What to confirm before you pay
FDA status of the finished product FDA-approved products exist Not FDA-approved Exact product on the prescription
Controlled substance Yes — Schedule III Yes — Schedule III Prescriber authority and state availability
Needles Yes No Whether needle avoidance is a preference or a real adherence barrier
Depends on skin absorption No Yes Follow-up testing and product-specific instructions
Transfer to other people No topical application-site pathway Topical exposure is a real concern; exact risk depends on the product and use Written handling instructions for the exact cream
Daily burden Schedule depends on the prescribed product Recurring topical use Which routine you can realistically follow
Level pattern Depends on formulation and injection schedule Depends on product, concentration, site, timing, and absorption Timing of follow-up blood work
Hematocrit Can increase; injections show larger increases than some transdermal products in several studies Can increase; direct cream-vs-injection evidence is limited Baseline and follow-up blood counts
Depth of evidence Strong product-specific labeling for approved products Less standardized because compounded products differ Whether a claim was actually studied on that product
Dose comparison Product-specific Product-specific Do not compare milligrams across formats as if absorption were identical
Fertility Exogenous testosterone can suppress sperm production Same core fertility issue Whether fertility matters now or soon
Insurance Approved products have a more realistic insurance path Compounded product coverage is less predictable and often poor Your plan's actual formulary and prior-authorization rules
Biggest practical drawback Needles plus formulation/schedule-dependent fluctuations Daily handling, absorption uncertainty, product variability, household precautions Which drawback matters in your real life

Is testosterone cream as effective as injections?

Both injections and topical testosterone can raise blood testosterone when an appropriate product is prescribed and used as directed. Injections are more predictable as a delivery route because they do not depend on skin absorption; a compounded cream can work, but its performance cannot be assumed from studies of a different gel or cream.

There is no honest milligram-for-milligram comparison between a shot and a cream. The products have different pharmacokinetics, the absorbed fraction is different, and the timing of the blood draw can change the measured number.

What we can say with confidence is where each route is fragile.

Injections are sensitive to formulation and timing. Testosterone concentrations can rise after an injection and fall before the next one. The pattern depends on the ester, product, and schedule set by the clinician.

Topicals are sensitive to skin, site, and routine. FDA-approved gel studies show that application site and what happens after application can change exposure. That does not mean the exact percentages from an AndroGel study apply to compounded cream. It proves the broader point: transdermal delivery is affected by how and where the product is used.

One useful piece of cream-specific evidence does exist. A published bioequivalence study found comparable testosterone exposure between one specific 5% testosterone cream and one specific 1% gel under the conditions studied. The cream was a registered Australian product, not a custom U.S. compounded cream. It shows that a cream formulation can deliver testosterone effectively; it does not prove that every compounded cream behaves like an FDA-approved gel.

And here is the part worth remembering: a higher testosterone number is not automatically a better result. Treatment goals are clinical, not a contest to reach the highest laboratory value. If a clinic sells the number instead of explaining the diagnosis, symptoms, monitoring, and tradeoffs, that is the wrong conversation.


Is testosterone cream FDA-approved?

No. Compounded testosterone creams are not FDA-approved finished drugs. FDA-approved testosterone products exist in other formats, including injections and topical gels, but an approved gel and a compounded cream are not interchangeable in labeling, strength, instructions, evidence, or insurance treatment.

Here is what changes when the finished product is compounded:

What to compare FDA-approved testosterone product Compounded testosterone cream
FDA reviewed the finished drug before approval Yes No
Standardized FDA labeling for that product Yes No FDA-approved product label
Product-specific pharmacokinetic data Usually available for the approved product Depends on the preparation; often limited
Product-specific transfer study Available for some approved topicals Usually not publicly available
Manufacturing framework FDA-approved manufacturers follow applicable federal drug manufacturing requirements 503A pharmacies and 503B outsourcing facilities operate under different federal compounding frameworks
Insurance path Can be covered depending on plan and criteria Often harder; verify with your plan
Pharmacy portability Ordinary retail/specialty pathways may be available Usually tied to a compounding pharmacy that can fill that prescription

The American Urological Association's guideline expresses a preference for commercially manufactured testosterone products over compounded testosterone when possible. That is not a ban on compounding. It is a reason to ask why the compounded product is being chosen for you.

Five questions to ask before you pay for any cream:

  1. What is the exact preparation — testosterone in what base and at what strength?
  2. Which pharmacy compounds it?
  3. Why is a compounded product being chosen instead of an FDA-approved testosterone product?
  4. What handling instructions apply to this exact product?
  5. What are all of the costs at the prescribed quantity, including membership, testing, shipping, and follow-up?

If a program cannot answer those in plain language, that tells you something.


Which one gives steadier levels — and how fast can you stop?

Neither route deserves the blanket label “stable.” Injection patterns depend on the exact product and schedule; topical exposure depends on the exact product, application conditions, and absorption. FDA-approved AndroGel 1.62% returns testosterone concentrations toward baseline within roughly 48 to 72 hours after the last dose, but that number cannot be assigned to every compounded cream.

This is one of the places where cream-vs-gel confusion creates bad advice.

The AndroGel 1.62% label gives us a measured off-ramp for that gel. It does not give us a published 48-to-72-hour clearance rule for whatever compounded cream a particular pharmacy makes.

Injected testosterone esters are longer acting than a daily topical, but the exact persistence depends on the product. That makes “how quickly can I stop?” a reasonable question for the prescribing clinician — not a reason to self-select or change treatment without them.

The more important off-ramp is clinical. If testosterone levels normalize but the symptoms that drove treatment do not improve, AUA guidance says the clinician and patient should discuss whether continuing testosterone makes sense.


Does one raise hematocrit more than the other?

Injectable testosterone has produced larger hematocrit increases than some transdermal formulations in several studies, but most of that evidence compares injections with gels or patches — not a specific compounded cream. All testosterone routes can raise red-cell measures, so baseline and follow-up monitoring matter either way.

Hematocrit is the percentage of your blood made up of red blood cells. Testosterone can increase red-cell production. If hematocrit rises too far, the clinician needs to evaluate the cause and treatment plan.

Here is what the comparative evidence actually says:

Source Study type What it found
Pastuszak et al., Sexual Medicine Retrospective clinic cohort Hematocrit above 50% occurred in 66.7% of men using injections, 12.8% using gels, and 35.1% using pellets in that cohort
AUA guideline evidence summary Guideline synthesis Injectable formulations showed larger mean hemoglobin increases than transdermal formulations in the cited trials
Journal of Urology network meta-analysis 29 placebo-controlled RCTs, 3,393 men Mean hematocrit increase was about 4.0% with IM enanthate/cypionate, 3.0% with gel, 1.6% with IM undecanoate, and 1.4% with patch
Blood Advances systematic review Systematic review Reported erythrocytosis rates varied widely across testosterone studies; intramuscular formulations generally showed higher rates than topical or pellet formulations

Those numbers do not prove that every compounded cream carries less hematocrit risk than every injection regimen. They do support a narrower conclusion: formulation matters, short-acting injections can show a stronger erythrocytosis signal, and cream-specific head-to-head evidence is thin.

The practical safeguards are more important than arguing over which study wins:

  • Check hemoglobin and hematocrit before treatment.
  • If baseline hematocrit is already elevated, the cause needs evaluation before simply pushing ahead.
  • AUA guidance uses hematocrit of 54% or higher during treatment as a level that warrants intervention.
  • Do not self-manage this by changing the dose or treating blood donation as a DIY solution.

If your blood counts have already been a problem, that is a reason for a clinician to reconsider the formulation and treatment plan — not proof that compounded cream is automatically the answer.


Can testosterone cream transfer to your partner or your kids?

Topical testosterone can expose another person through skin contact. The best quantified evidence comes from FDA-approved gels, not compounded cream, so the exact transfer percentage for your cream may be unknown. That uncertainty is a reason to get written handling instructions for the actual prescription.

This is the section we would keep if we had to delete most of the page.

AndroGel 1.62% carries a boxed warning about secondary exposure. Its prescribing information includes a controlled transfer study:

What was tested Contact condition Result in the untreated female partner
Gel on shoulders/upper arms, site uncovered 15 minutes of direct contact two hours after application Average testosterone exposure increased about 280%; peak concentration about 267%
Same application site covered by a T-shirt Same contact through the shirt Average exposure increased about 6%; peak about 11%

Those are striking numbers — but they belong to AndroGel 1.62% under the tested conditions. They are not a transfer study of Male Excel cream, Hone cream, or another compounded product.

The current AndroGel label also instructs users to wash their hands after application, let the site dry, cover it with clothing, and wash the application site before expected skin-to-skin contact. It documents cases of secondary exposure in children with signs of virilization or early puberty.

For a compounded cream, do not copy the AndroGel application site or timing instructions and assume they are correct. Ask the prescriber or dispensing pharmacy for the written instructions for that exact product.

The practical conclusion is still clear: if reliable topical-contact precautions are unrealistic in your household, a non-topical testosterone format removes that application-site transfer pathway.

▶ If topical transfer is the problem you have already resolved

Taurus Meds currently advertises a testosterone cypionate program and a separate gel option, not a distinct cream. That makes it more relevant once you have already decided you want injections rather than a compounded cream.

Review Taurus Meds' testosterone cypionate offer and the questions we think you should ask first →

Affiliate link. Taurus publicly advertises a cash-pay program. TRT Provider Guide has not independently confirmed the exact dispensed cypionate product or pharmacy assignment for every patient; verify those details before paying.


What do injections and cream really cost in the first year?

The medication sticker price is not the full bill. A useful comparison includes intake/testing, membership or clinician fees, medication, repeat monitoring, shipping, and the billing cadence. Current provider pages let us model the published fees, but shipping or charge timing prevents one universal “complete first-year” number for every program.

Public-fee models checked in September 2026

Care route / provider Format Published starting fees we could verify 12-month service-cost model* What can still change the first-year cash total
Own prescriber + retail pharmacy FDA-approved injection GoodRx listed testosterone cypionate starting around $29.95 at audit time Cannot model honestly without the prescribed quantity and visit/lab costs Pharmacy, location, strength, quantity, insurance, clinician and lab charges
Male Excel Testosterone cypionate program $99 start; $99/mo membership; medication from $120/mo equivalent $2,727 + shipping Shipping, prescribed quantity, additional care; 60-day billing timing can change cash outlay
Male Excel Compounded cream program $99 start; $99/mo membership; medication from $132/mo equivalent $2,871 + shipping Same billing/shipping caveats
Hone Health Testosterone cypionate $45 initial test; confirmatory test may be $45 in-lab or $80 at home; $135/mo membership; medication from $28/vial About $2,046–$2,081 if TRT confirmatory testing is required Medication quantity, clinician decision, and any care not included in the published plan
Hone Health Compounded cream Same testing/membership; cream from $60/mo About $2,430–$2,465 if TRT confirmatory testing is required Prescribed quantity and any care outside published inclusions
Taurus Meds Testosterone program $49 blood-test/consult offer; provider advertises $149/mo if approved About $1,837 using one $49 intake charge + twelve $149 program charges Product identity, fulfillment details, state access, and exact terms at checkout

*These are reproducible models from public pricing, not personalized quotes. For Male Excel, the 12-month model annualizes the published monthly-equivalent medication rate. Its page also describes 60-day supplies billed every other month; depending on the first charge date, a seventh 60-day medication charge can land within 365 days, which would increase first-year cash outlay even though it buys more than twelve months of medication. Verify the billing schedule before paying.

Three things fall out of this table.

1. Inside a membership program, the membership can be a bigger decision than the format. Male Excel's published monthly-equivalent difference between injection and cream is $12. Hone's current starting medication difference is $32 a month. If you are choosing inside one program, the care model may matter more than a small medication-price gap.

2. A cheap vial is not a complete TRT budget. A retail discount price excludes the clinician, diagnostic confirmation, monitoring, and whatever repeat testing the clinician requires. It can still be the cheapest care route if you already have appropriate medical care.

3. Insurance is usually a product-and-care-route question, not an affiliate-provider question. FDA-approved products have a more realistic insurance pathway than compounded cream, but coverage and prior-authorization criteria vary by plan. Do not assume a cash-pay telehealth membership will be reimbursed because the medication exists in an approved form.

We removed one stale price from the earlier draft while auditing this page: Hone now lists a $45 initial test, not $65, and its current page separates the possible confirmatory test cost.


Side effects: injections vs cream, head to head

Most testosterone-related risks come from testosterone exposure itself. The format-specific differences are practical: injections add needle and injection-site issues and show a stronger hematocrit signal in some studies; topical treatment adds skin reactions, absorption variables, and secondary-exposure concerns.

A useful safety example comes from the FDA-approved AndroGel 1.62% trial. This is gel data, not compounded-cream data:

Reported adverse reaction in the 182-day trial AndroGel 1.62% (n=234) Placebo (n=40)
PSA increased 11.1% 0%
Emotional lability 2.6% 0%
Hypertension 2.1% 0%
Hematocrit or hemoglobin increased 2.1% 0%
Contact dermatitis 2.1% 0%

The broader shared issues include acne, edema or fluid retention, changes in red-cell measures, suppression of sperm production, and product-specific prostate or blood-pressure monitoring considerations.

Injection-specific practical issues: needles, injection-site reactions, and concentration changes that depend on the formulation and prescribed schedule.

Cream-specific practical issues: skin irritation, a recurring application routine, absorption variability, compounded-product variability, and secondary exposure.

One current labeling change is worth knowing. On February 28, 2025, FDA announced class-wide testosterone labeling changes after the TRAVERSE trial. FDA required removal of boxed-warning language about increased cardiovascular risk and required blood-pressure warnings across testosterone products that did not already have them. That did not remove the separate secondary-exposure boxed warning from topical gel products.

The earlier version of this page said Xyosted still had its own boxed warning for blood-pressure increases. That is no longer current. Xyosted's boxed blood-pressure warning was removed in March 2025; its current labeling still warns that blood pressure can increase and calls for periodic monitoring.


Does testosterone cream raise DHT more than injections?

Scrotal testosterone cream can produce substantial increases in DHT, but the published cream study most often cited did not compare that DHT response head-to-head with injectable testosterone. It therefore cannot prove that every compounded cream raises DHT more than every injection regimen.

DHT — dihydrotestosterone — is an androgen made from testosterone through the enzyme 5-alpha-reductase. Skin can contribute to that conversion, and application site matters.

A 2017 pharmacokinetic study of testosterone cream applied to scrotal skin found rapid testosterone absorption. In that study, a 25 mg dose maintained physiologic testosterone concentrations for about 16 hours, and DHT peaked around 1.2 ng/mL several hours after application. The study was small, used a particular cream under controlled conditions, and did not establish that higher DHT improves outcomes.

That last point matters because DHT is often sold as a benefit.

You may see higher DHT framed as a shortcut to better erections, more energy, more muscle, easier fat loss, or a more “powerful” form of TRT. We could not verify that chain of promises from the cream pharmacokinetic evidence.

Two facts are more useful:

  • FDA-approved gels have product-specific approved application sites; they should not be applied to the genitals unless the label for that exact product says so.
  • A compounded cream may have different instructions. If scrotal application is proposed, ask why, ask what evidence supports the exact approach, and ask what the clinician plans to monitor.

Do not copy an application site or dose from another product or from an internet protocol.


Does either one protect your fertility?

No. Changing from injections to cream does not turn exogenous testosterone into a fertility-preserving treatment. Testosterone from outside the body can suppress the hormonal signals that support sperm production, so men trying to conceive now or planning fertility in the near term should raise that before choosing a formulation.

This is one place where the format debate can distract from the bigger decision.

Endocrine Society guidance recommends against starting testosterone in men planning fertility in the near term. AUA guidance likewise says men currently trying to conceive should not receive exogenous testosterone.

The AndroGel label warns that exogenous androgens can suppress spermatogenesis and that fertility effects may be irreversible in some patients. That is a warning about risk, not a prediction that every man will become infertile or that recovery can never occur.

There are other medicines used in fertility-aware male care, including hCG and selective estrogen receptor modulators such as clomiphene. They are not testosterone replacement therapy, and their approval status and evidence are not interchangeable. Enclomiphene is not an FDA-approved testosterone-replacement drug. This is a specialist conversation, not a reason to shop for a substitute by name.

If fertility is part of the plan, the next useful decision is usually the clinician — often reproductive urology, urology, or endocrinology — not injection versus cream.

▶ Not sure whether this is a format question or a bigger one?

If low testosterone has not been properly evaluated, fertility is on the table, or you are not sure whether online care fits your situation at all, start there instead of at a checkout page.

Use Find My TRT Path to map your care route and the questions to ask before you pay →

Free, educational, and non-diagnostic. It does not confirm low testosterone, clear contraindications, determine medical eligibility, or guarantee a prescription.


Which one will you actually stick with?

Adherence matters. Cream removes the needle but adds a recurring skin routine and handling precautions; injections avoid topical handling but add needles, supplies, and sharps disposal. The useful question is not which routine looks easiest today — it is which medically appropriate routine you can still follow months from now.

Be honest with yourself about month nine, not week one.

Daily friction with a topical: travel, showers, skin-to-skin contact, children in the house, clothing, and remembering the application routine exactly as prescribed.

Friction with injections: the needle itself, supplies, sharps disposal, travel with medication, and following the prescribed injection schedule.

If needles are the reason you know you would not follow an injection plan, say that at the consultation. That is not a character flaw. It is information the clinician needs when choosing a realistic treatment plan.

One practical issue has been documented with testosterone gel users: contamination of the venipuncture site can falsely raise a testosterone blood result. In a 13-year retrospective review, 48 of 578 gel users had at least one result above 1,000 ng/dL, and seven cases strongly supported topical gel contamination as the explanation.

If you use a topical testosterone product, tell the clinician and phlebotomy team what you use and where you apply it so they can avoid a contaminated sampling site. Do not change the product, dose, or application routine on your own to “fix” a lab result.


What if your pharmacy cannot get testosterone cypionate?

Testosterone cypionate has had intermittent U.S. supply problems. ASHP's shortage page, last updated March 5, 2026, still listed affected products, while some manufacturers had product available. This is a manufacturer-and-product-specific supply issue, not proof that every pharmacy will be out.

The ASHP bulletin listed Pfizer's Depo-Testosterone as affected by manufacturing delays while other manufacturers had certain products available.

This is not a reason to rush into a program. It is a good pre-pay question:

“If the prescribed product is unavailable at my pharmacy, what is the backup plan, and would that change the product or cost?”

FDA rules can allow certain compounded copies when an approved drug is on the shortage list and the statutory conditions are met. That is one legitimate situation in which compounding can matter.


Who shouldn't pick a format online first?

If low testosterone has not been properly evaluated, or your history suggests a more complicated cause or higher-risk situation, choosing cream versus injections is not the first job. Current guidance calls for symptoms or signs plus consistently low testosterone confirmed with repeat early-morning testing and appropriate evaluation of the cause.

AUA guidance uses total testosterone below 300 ng/dL as a reasonable cutoff in support of the diagnosis, but it does not turn one result into a diagnosis. It also calls for two total testosterone measurements on separate occasions, both obtained early in the morning, plus compatible symptoms or signs.

The Endocrine Society similarly recommends diagnosis only when symptoms or signs occur with unequivocally and consistently low testosterone, confirmed with repeat morning fasting measurement using accurate testing.

Start with primary care, urology, endocrinology, reproductive urology, or another appropriate in-person setting when the history or findings need broader evaluation — for example:

  • you only have one low result or the test conditions were not appropriate;
  • you are trying to conceive now or planning fertility in the near term;
  • you have a history of prostate or breast cancer;
  • baseline hematocrit is elevated;
  • you have untreated severe sleep apnea;
  • you had a recent myocardial infarction or stroke;
  • the pattern suggests pituitary or testicular disease or another cause that needs workup.

No online quiz confirms low testosterone, and no intake form guarantees a prescription.


Can you get injections or cream by telehealth right now?

Yes, federal telemedicine flexibilities for prescribing controlled medications remain extended through December 31, 2026 when the federal requirements are met. State law, professional licensure, DEA requirements, and the provider's own state coverage still apply, so this is not permission for every clinic to prescribe testosterone to every patient nationwide.

Testosterone is a Schedule III controlled substance in the United States and requires a valid prescription.

DEA and HHS extended the federal telemedicine flexibilities through December 31, 2026. Under the extension, qualifying DEA-registered practitioners can prescribe Schedule II–V controlled medications through telemedicine without a prior in-person medical evaluation when the applicable requirements are satisfied.

That federal rule does not erase state law or guarantee that a specific provider can serve you. Before paying, ask:

  • Does the program currently have an authorized prescriber for my state?
  • Will an in-person evaluation be required in my situation?
  • What happens to follow-up and refills if federal or state rules change?

This section should be re-verified before the end of 2026 because the federal temporary extension has a fixed end date.


Which providers actually offer which format?

Program menus are not interchangeable. Male Excel currently publishes both testosterone cypionate and compounded cream options. Hone Health also lists testosterone cypionate and compounded cream. Taurus Meds publishes testosterone cypionate and gel, not a separate cream, so it is more relevant after a reader has already chosen an injection or gel path.

Provider Injection Cream Published recurring fee structure Testing / monitoring disclosed publicly Insurance position Best role in this decision
Male Excel Yes — testosterone cypionate program Yes — compounded Lipoderm cream $99/mo membership + medication from $120/mo injection or $132/mo cream; shipping separate Comprehensive blood testing every six months and recurring provider review are advertised Cash-pay; says approach is not covered by insurance Useful if you want one program that publicly lists both formats
Hone Health Yes — testosterone cypionate from $28/vial Yes — compounded cream from $60/mo $135/mo Plus membership + medication $45 initial at-home test; TRT confirmatory testing may add $45 in-lab or $80 at home; follow-up labs/consults advertised as included Does not bill insurance for membership/treatment; HSA/FSA may be usable depending on plan Useful non-affiliate benchmark for a program offering both formats
Taurus Meds Yes — provider advertises testosterone cypionate No separate cream listed $49 blood-test/consult offer; provider advertises $149/mo after approval Provider advertises LabCorp/Quest testing and monitoring, but exact product/pharmacy details need confirmation Cash-pay offer Useful once you have already decided toward injections; confirm exact dispensed product
Your own prescriber FDA-approved options can be prescribed when appropriate A clinician may use a compounding pharmacy when appropriate Depends on clinician, pharmacy, and insurance Depends on care setting The most realistic route for using insurance on an FDA-approved product Often the lowest-cost route if you already have appropriate care

Male Excel: why it is the main commercial fit here

The useful part is not that Male Excel “wins TRT.” It does not.

The useful part for this exact decision is that its public treatment menu includes both injection and compounded cream. If you are specifically undecided on format, that means you do not have to choose a clinic solely because it sells only one of the two.

The damaging admission: Male Excel does not solve the FDA-approval problem for cream. Its topical product is compounded, and its public program pricing is higher than simply getting an FDA-approved testosterone prescription through a clinician and retail pharmacy when that lower-cost route is available to you.

Its public pricing also bundles testosterone products with thyroid medication in certain packages. Thyroid medication should have its own clinical reason. Ask what exact drugs are being proposed, why each is being prescribed, whether each is optional, and what the price is without anything you do not need.

If FDA-approved topical labeling or insurance coverage is your priority, an approved topical product through an appropriate prescriber may fit better than a compounded cream.

Hone Health: useful benchmark, not the CTA we are pushing

Hone currently publishes both cypionate and compounded-cream prices, so it is useful for price comparison. Its September 2026 page lists a $135 monthly Plus membership, a $45 initial at-home test, possible confirmatory testing for TRT, injection medication starting at $28 per vial, and compounded cream starting at $60 per month.

That makes Hone useful evidence even if you never click a commercial link.

Taurus Meds: resolve the product identity first

Taurus advertises a simple $49 testing/consult offer and a $149 monthly program after approval. Its public product page lists cypionate and a gel, not a separate cream.

Its marketing copy also contains repeated product-card language that is not reliable enough for us to use as proof of the exact dispensed formulation or pharmacy assignment. Before paying, get the exact product, pharmacy, strength, recurring testing plan, state availability, and total terms in writing.


What we actually verified

Verification date September 2026
Regulatory and clinical sources checked directly Current FDA testosterone information and labeling updates; current AndroGel 1.62% labeling; current Xyosted labeling; FDA compounding guidance; DEA drug scheduling; HHS/DEA 2026 telemedicine extension; Endocrine Society testosterone guidance and 2026 diagnostic statement; AUA testosterone-deficiency guidance; ASHP testosterone-cypionate shortage bulletin
Research checked Comparative hematocrit studies and meta-analysis; testosterone-cream pharmacokinetics; cream/gel bioequivalence study; topical-gel venipuncture contamination case series
Provider pages checked directly Male Excel pricing/treatment pages; Hone Health Plus/TRT pricing pages; Taurus Meds testosterone offer page
Recalculated Male Excel published-fee models; Hone current first-year published-fee models using its September 2026 testing prices; Taurus simple public-fee model
Provider-stated, not independently confirmed for each patient Assigned clinician, state-by-state availability at time of intake, exact pharmacy assignment, fulfillment timing, and whether a given reader will be prescribed a particular formulation
What we did not claim That compounded cream is equivalent to an FDA-approved gel; that cream is universally safer; that injections universally work better; that any provider will prescribe testosterone; that a specific dose, schedule, or application site is correct for you

So — injections or cream?

If both are clinically appropriate, an FDA-approved injection is the more evidence-supported default when you do not have a strong reason to use a compounded topical. Cream becomes more compelling when needles are a genuine barrier or a clinician has a patient-specific reason for compounding — but it brings product-specific absorption, handling, and FDA-status questions you should resolve first.

Find yourself here:

You have young children or a pregnant partner at home → A non-topical format removes the application-site transfer pathway. If topical precautions would be hard to follow reliably, say that before a formulation is chosen.

Needles are a genuine blocker → Discuss a topical. If FDA-approved-product status matters to you, ask about an approved gel before assuming compounded cream is the only needle-free choice.

You want insurance to help pay → Start with an FDA-approved product through a prescriber who works with your plan. Coverage and prior authorization vary; do not assume compounded cream will be covered.

Your hematocrit has run high before → Do not self-switch formats. Injectable testosterone shows a stronger erythrocytosis signal than some transdermal products in several studies, but compounded-cream-specific comparative evidence is limited. This is a monitoring and treatment-plan discussion.

You are not sure testosterone is right for you → Resolve the diagnosis and clinical reason for treatment before comparing formats.

You want one program that publicly offers both injections and compounded cream → Male Excel is relevant to investigate because it lists both. Its higher cash-pay cost and compounded topical are real tradeoffs.

You are trying to conceive now or planning fertility in the near term → Neither format should be chosen casually. Start with fertility-aware care.

▶ Want the format decision made with you instead of for you?

Male Excel publicly lists both compounded testosterone cream and testosterone cypionate programs, plus an ongoing membership with clinician access and monitoring. Check the current price, what testing is included, the exact products being proposed, and whether it can serve your state before you pay.

See Male Excel's current pricing and what we verified →

Affiliate link. Cash-pay program. Verified September 2026. No program can promise a prescription — that is a clinical decision.


How we compared these

TRT Provider Guide's documented method, How We Review TRT Providers, separates verified facts, provider-stated facts, customer-experience signals, and editorial conclusions. For this page, medical and regulatory claims come from primary or specialty sources, while provider prices and features carry a September 2026 verification date.

We compared the formats across regulatory status, exact formulation, evidence depth, absorption, household exposure, hematocrit, fertility, monitoring, routine burden, public cost, provider availability, and pharmacy transparency.

Where a claim came from a company, we say so. Where it came from an FDA label, government rule, guideline, or published study, we identify that source. Where a commercial fact could not be independently confirmed, we do not turn it into a certainty.


Common questions

Is testosterone cream as effective as injections?

Both can raise blood testosterone when an appropriate product is prescribed and used correctly, but there is no valid milligram-for-milligram comparison between them. Injections avoid skin-absorption variability; a compounded cream's performance depends on the exact formulation and patient, and evidence from a different gel cannot automatically be applied to it.

Is testosterone cream FDA-approved?

No. Compounded testosterone creams are not FDA-approved finished drugs. FDA-approved topical testosterone products exist, but an approved gel and a compounded cream should not be treated as interchangeable.

What's the difference between testosterone cream and testosterone gel?

An FDA-approved gel has standardized product labeling and product-specific evidence reviewed as part of FDA approval. A compounded cream is prepared by a compounding pharmacy for a prescription and can differ in base, concentration, instructions, and evidence. If gel is what you are actually weighing, see our testosterone injections vs gel comparison.

Does testosterone cream cause less thick blood than injections?

You cannot make that blanket claim from the available evidence. Injections have produced larger hematocrit increases than some gels and patches in several studies, but those studies do not establish the risk of every compounded cream. Blood counts need monitoring either way.

Can testosterone cream transfer to my wife, partner, or children?

Topical testosterone can create secondary-exposure risk. The strongest quantified data come from FDA-approved gel studies, not compounded cream. Get written handling instructions for the exact prescribed product and do not assume another topical's application rules apply.

Can I have skin-to-skin contact after using testosterone cream?

The safe timing and cleaning instructions depend on the exact product. FDA-approved gels have their own label instructions; a compounded cream can use different sites, concentrations, or bases. Ask the prescriber or pharmacy for the written instructions for your prescription rather than borrowing a gel protocol.

Does testosterone cream affect sperm count?

It can. Exogenous testosterone can suppress spermatogenesis regardless of whether it comes from an injection or topical product. If you are trying to conceive now or planning fertility in the near term, discuss that before starting testosterone.

Is testosterone cream cheaper than injections?

Not necessarily. Inside cash-pay telehealth programs, membership and monitoring can dominate the bill. Male Excel's current published monthly-equivalent medication gap is only $12 between its injection and cream starting prices; Hone's current starting medication gap is $32 a month. Your complete cost depends on testing, membership, shipping, prescribed quantity, and billing cadence.

Does insurance cover testosterone cream?

Compounded cream often has a harder insurance path than FDA-approved testosterone products. Coverage varies by plan, diagnosis, product, and prior-authorization criteria, so verify the exact prescription with your insurer rather than assuming either coverage or denial.

How long does testosterone cream take to work?

A topical testosterone product can change blood testosterone within hours, but symptom response is a different question and varies by person and condition. Do not use a pharmacokinetic peak from a small cream study as a promise about how quickly you will feel different.

Can I switch from injections to cream, or back?

A clinician can change the prescribed formulation when appropriate, but it is not a milligram-for-milligram swap and should not be done on your own. The new product may require different instructions and follow-up testing.

Do I have to inject into muscle?

Different FDA-approved testosterone products use different administration routes, and clinicians may use product-specific approaches. This page is not an injection technique guide; follow the exact product labeling and clinician instructions rather than copying a route or technique from another testosterone product.

What if my pharmacy can't get testosterone cypionate?

Supply can vary by manufacturer and product. ASHP's testosterone-cypionate shortage page was still listing affected products when last updated March 5, 2026, while some manufacturers had product available. Ask what the backup plan would be before paying for a program.

Is testosterone a controlled substance, and does that change how I get it online?

Yes. Testosterone is Schedule III in the United States and requires a valid prescription. Federal telemedicine flexibilities remain extended through December 31, 2026 when requirements are met, but state law, licensing, DEA rules, and provider coverage still apply.


Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.

It is educational and non-diagnostic. It does not confirm low testosterone, clear contraindications, decide medical eligibility, or replace a clinician. It helps you sort the questions that matter — diagnosis, state, household, fertility, insurance or cash pay, and treatment-format preference — so you know what to ask before you pay.

Use Find My TRT Path →

Related reading: Testosterone injections vs gel · TRT without needles · Male Excel testosterone cream · Testosterone cream cost · How We Review TRT Providers


Sources

  1. U.S. Food and Drug Administration — Testosterone Information. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/testosterone-information
  2. U.S. Food and Drug Administration — Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  3. DailyMed — AndroGel 1.62% prescribing information, current label. https://dailymed.nlm.nih.gov/
  4. U.S. Food and Drug Administration — FDA issues class-wide labeling changes for testosterone products, February 28, 2025. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-issues-class-wide-labeling-changes-testosterone-products
  5. DailyMed — Xyosted (testosterone enanthate) prescribing information, current label. https://dailymed.nlm.nih.gov/
  6. Drug Enforcement Administration — Drug Scheduling. https://www.dea.gov/drug-information/drug-scheduling
  7. U.S. Department of Health and Human Services — DEA/HHS telemedicine extension through December 31, 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
  8. Endocrine Society — Testosterone Therapy in Men With Hypogonadism clinical practice guideline. https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy
  9. Endocrine Society — 2026 statement on appropriate diagnosis and treatment of hypogonadism. https://www.endocrine.org/
  10. American Urological Association — Evaluation and Management of Testosterone Deficiency guideline. https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
  11. Pastuszak AW et al. Comparison of testosterone gels, injections, and pellets on serum hormones, erythrocytosis, lipids, and PSA. Sexual Medicine.
  12. The effect of route of testosterone on changes in hematocrit: systematic review and Bayesian network meta-analysis. Journal of Urology.
  13. Diagnosis, management, and outcomes of drug-induced erythrocytosis: systematic review. Blood Advances.
  14. Iyer R et al. Pharmacokinetics of testosterone cream applied to scrotal skin. Andrology. https://pubmed.ncbi.nlm.nih.gov/28334510/
  15. Bioequivalence study of a 5% testosterone cream and 1% testosterone gel. https://pubmed.ncbi.nlm.nih.gov/26754331/
  16. Falsely elevated serum testosterone measurements from topical gel contamination of the venipuncture site. https://pmc.ncbi.nlm.nih.gov/articles/PMC10716548/
  17. ASHP — Drug Shortage Detail: Testosterone Cypionate Injection, last updated March 5, 2026. https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=592
  18. Male Excel — Hormone treatment costs and current treatment pages. https://maleexcel.com/treatments/hrt-costs/
  19. Hone Health — Current TRT / Plus pricing and testing information. https://honehealth.com/
  20. Taurus Meds — Testosterone program page. https://taurusmeds.com/pages/testosterone-49
  21. GoodRx — Testosterone cypionate discount pricing, checked September 2026. https://www.goodrx.com/testosterone-cypionate

Ready to explore your options?

Our tool helps you narrow down the care route that fits your situation based on testing, budget, and fertility goals.

Find My TRT Path

Not sure which TRT route fits you?

Find My TRT Path